Surveys Fail To Achieve Consensus On Global Technology Leadership

Last fall Congress gave Leo Young a tall order. In four months, Young—a staff specialist at the Department of Defense—was to pick 20 or so technologies deemed crucial for future national security and assess where the United States ranked, compared with other nations, in developing those technologies. The congressional request re flects the recent national preoccupation with icoking over its shoulder to see which countries are challenging its technological superiority. Ever since P

Written byElizabeth Pennisi
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Last fall Congress gave Leo Young a tall order. In four months, Young—a staff specialist at the Department of Defense—was to pick 20 or so technologies deemed crucial for future national security and assess where the United States ranked, compared with other nations, in developing those technologies.

The congressional request re flects the recent national preoccupation with icoking over its shoulder to see which countries are challenging its technological superiority. Ever since President Reagan targeted U.S. preeminence as a national goal in his 1987 State of the Union address, competitiveness has become an intemational battle cry. All over the world, government officials, corporate executives, and academic scientists are polling expert observers, issuing reports, and spending money to size up research and development trends. But are these assessments really useful? Many observers believe that, apart from their ability to generate dramatic headlines, most of these surveys do more to confuse than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies